Audrey Finesso, PharmD, MSc
Senior Director, Clinical Regulatory Strategy
Dr. Audrey Finesso is a Global Senior Director and Clinical Regulatory Strategist at Fortrea with more than 25 years of experience in regulatory affairs and drug development. Based remotely in France near Switzerland, she provides clinical and regulatory strategy to support global development programs, with deep experience in oncology and rare and orphan diseases.
Prior to joining Fortrea, Audrey was Head of the Drug Development Unit at PharmaLex in France for five years, where she led clinical and regulatory strategy and coordinated interactions with major EU and U.S. health authorities, including the FDA, EMA, ANSM, and BfArM. Earlier in her career, she held regulatory affairs roles for more than 17 years at leading biotechnology and pharmaceutical companies, including Amgen, Biogen, Merck Serono, Gedeon Richter, MSD, and Janssen Cilag.
Audrey holds a PharmD from Claude Bernard University in Lyon and an MSc in International Drug Registration and Development from Paris-Saclay University.